Document Detail

Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups.
MedLine Citation:
PMID:  22337359     Owner:  NLM     Status:  Publisher    
BACKGROUND: Comparative effectiveness research (CER) is an emerging field that compares the relative effectiveness of alternative strategies to prevent, diagnose, or treat patients who are typical of day-to-day practice. We developed a priority list of CER topics for inflammatory bowel disease (IBD). METHODS: Following the Institute of Medicine's approach, we developed and administered a survey to gastroenterologists asking for important CER topics in IBD. Two patient focus groups were convened to solicit additional CER studies. CER topics were presented to the expert panel using the RAND/UCLA methodology. Following initial ratings, the panel met to discuss and re-rate priorities. The top 10 CER topics were identified using a point-allocation system. RESULTS: Responses were collated into 234 CER topics across 21 categories, of which 87 were prioritized for discussion and re-rated. Disagreement regarding priorities was observed in 5 of 87 studies. We utilized a point-allocation system to prioritize the top-10 CER topics. These related to comparing the effectiveness of: biomarkers in IBD; withdrawal of anti-tumor necrosis factor (TNF) or immunomodulators for Crohn's disease in remission; mucosal healing as an endpoint of treatment; infliximab levels versus standard infliximab dosing; anti-TNF monotherapy versus combination therapy in patients failing thiopurines; safety of long-term treatment options; anti-TNF versus thiopurines for prevention of postoperative recurrence; and treatment options for steroid-refractory UC. CONCLUSIONS: We systematically developed a list of high-priority IBD topics for CER based on a survey of gastroenterologists, expert review, and patient input. This list may guide IBD research toward the most important CER studies. (Inflamm Bowel Dis 2012;).
A S Cheifetz; G Y Melmed; B Spiegel; J Talley; S M Devlin; L Raffals; P M Irving; J Jones; G G Kaplan; P Kozuch; M Sparrow; F Velayos; L Baidoo; B Bressler; C A Siegel
Related Documents :
952339 - Treatment of cholecystitis: cholecystostomy or cholecystectomy?
25008459 - Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.
17094759 - Salvage laparoscopic pyeloplasty in the worst case scenario: after both failed open rep...
10931019 - Laparoscopic compared with open methods of groin hernia repair: systematic review of ra...
19692879 - Prospective analysis of 101 consecutive cases of laparoscopic cholecystectomy for acute...
21377649 - Low weight-for-age z-score and infection risk after the fontan procedure.
23331739 - Topical tacrolimus 0.1% ointment for treatment of cutaneous crohn's disease.
24264889 - The importance of instrument type in paediatric percutaneous nephrolithotomy.
12105359 - Risk of endovascular treatment of brain arteriovenous malformations.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-15
Journal Detail:
Title:  Inflammatory bowel diseases     Volume:  -     ISSN:  1536-4844     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508162     Medline TA:  Inflamm Bowel Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fluorescence Properties of Carba Nicotinamide Adenine Dinucleotide for Glucose Sensing.
Next Document:  Cranial suture biology: from pathways to patient care.